BRIDION®

Drug Information Related Patent
Hold Company
MERCK SHARP DOHME
Dosage and Administration
SOLUTION;INTRAVENOUS
Specification
EQ 500MG BASE/5ML (EQ 100MG BASE/ML); EQ 200MG BASE/2ML (EQ 100MG BASE/ML)
Indication
BRIDION® is indicated for reversal of neuromuscular blockade caused by rocuronium and vecuronium in adult and pediatric patients 2 years of age and older undergoing surgery.
API
SUGAMMADEX SODIUM
API Structure
Drug Patent
Patent NoExpiration Date
RE447332026/1/27
API Patent
Patent NoExpiration Date
RE447332026/1/27
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

CONTACT US
  • Tel:
  • E-mail:
  • Address:
  • WhatsAPP
    WhatsAPP
Privacy Policy | Cookie Policy
Copyright © Protheragen-ING. All Rights Reserved.
Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Top